CompletedPhase 4

Efficiency of Autologous Amniotic Fluid Injection in the Healing of Cesarean Section Scar in High-Risk Population

Egypt108 participantsStarted 2024-02-16

Plain-language summary

The goal of this randomized controlled trial is to investigate the effect of injection of autologous amniotic fluid in the healing of the scar of cesarean section among high-risk population. Investigator's aim is to know : quality of wound healing, rate of infection and time needed for complete healing. Participants will be divided into two groups. All participants will undergo cesarean section. We will inject autologous amniotic fluid in the edges of the wound during skin closure in half of the participants. Wound healing will be assessed at 1st, 2nd and 6th week postoperatively.

Who can participate

Age range30 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age \> 30 years old. * Anemic patients * Maternal chronic disease e.g., Diabetes and Hypertension * BMI of \> 25 Kg/m2. * Underwent previous CS. Exclusion Criteria: * Rupture of membrane. * No previous section. * Anhydraminos. * Congenital malformation of the fetus.

What they're measuring

Quality of wound healing

Timeframe: 1,2,6 weeks postoperative

Trial details

NCT IDNCT06531356

SponsorKasr El Aini Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-05-16

View on ClinicalTrials.gov More High Risk Pregnancy trials